BioSig’s Signal Processing Technology for Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhythmia Technologies Retreat
Summary
Mr. Olivier Chaudoir, BioSig’s Senior Director of Marketing, will demonstrate the applications of the newest software features of the Company’s PURE EP(tm) System in clinical practice. The , released in April 2021, added valuable tools to shorten system setup time and brought a range of innovative features for advanced signal analysis. We would like to thank Dr. Wang and the faculty for the outstanding agenda that highlights innovation in this crucial area of arrhythmia care,” added Olivier Chaudoir, Senior Director of Marketing of BioSig Technologies, Inc. The Retreat is designed to serve as an expert forum of key thought leaders and innovators to share their ideas about new and emerging technologies in arrhythmia management and diagnosis. Physicians and scientists will be asked to give brief talks about the emerging developments in their field, the key needs in cardiac arrhythmias in their area of expertise, and the likely solutions in the next five years.